Expression of NF-κB, CD68 and CD105 in carotid atherosclerotic plaque

Journal of Thoracic Disease

Volumn 5, Issue 6, 2013, Pages 771-776

  Ren, Shiyan ^a   Fan, Xueqiang ^a   Peng, Liang ^a   Pan, Lin ^a   Yu, Changan ^a   Tong, Jie ^a   Zhang, Wenjian ^a   Liu, Peng ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Carotid stenosis; CD105; CD68; Nuclear factor kappa (NF B); Vulnerable plaque

Indexed keywords

CD68 ANTIGEN; ENDOGLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE MIGRATION; MALE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SYMPTOMATOLOGY; TISSUE DISTRIBUTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION;

EID: 84892407397     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.12.36     Document Type: Article

References (25)

1. Ren S, Liu P, Ma G, et al. Long-term outcomes of synchronous carotid endarterectomy and coronary artery bypass grafting versus solely carotid endarterectomy. Ann Thorac Cardiovasc Surg 2012;18:228-35.
2. Van Lammeren GW, Reichmann BL, Moll FL, et al. Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting. Stroke 2011;42:2550-5.
3. Vavuranakis M, Sigala F, Vrachatis DA, et al. Quantitative analysis of carotid plaque vasa vasorum by CEUS and correlation with histology after endarterectomy. Vasa 2013;42:184-95.
4. Kadoglou NP, Sailer N, Moumtzouoglou A, et al. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J Vasc Surg 2010;51:114-21.
5. Wang J, Razuvaev A, Folkersen L, et al. The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of igf binding protein-1 in the regulation of smooth muscle cell proliferation. Atherosclerosis 2012;220:102-9.
6. Gao T, He X, Yu W, et al. Atherosclerotic plaque pathohistology and classification with high-resolution mri. Neurol Res 2011;33:325-30.
7. Razuvaev A, Ekstrand J, Folkersen L, et al. Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg 2011;42:722-30.
8. Pelisek J, Well G, Reeps C, et al. Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J 2012;76:1274-82.
9. Yuan XM, Osman E, Miah S, et al. P53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations. Atherosclerosis 2010;210:392-9.
10. Chowdhury M, Ghosh J, Slevin M, et al. A comparative study of carotid atherosclerotic plaque microvessel density and angiogenic growth factor expression in symptomatic versus asymptomatic patients. Eur J Vasc Endovasc Surg 2010;39:388-95.
11. Pilarczyk K, Sattler KJ, Galili O, et al. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 2008;196:333-40.
12. Shaikh S, Brittenden J, Lahiri R, et al. Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur J Vasc Endovasc Surg 2012;44:491-7.
13. Marzullo A, Ciccone MM, Covelli C, et al. Macrophages and mast cells are involved in carotid plaque instability. Rom J Morphol Embryol 2011;52:981-4.
14. Martín-Ventura JL, Blanco-Colio LM, Muñoz-García B, et al. NF-kappab activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke 2004;35:458-63.
15. Jiang X, Dong S, Liao Y, et al. The role of NF-kappa B and I-kappa B in intimal proliferation following balloon catheter-induced injury in the rat carotid artery. J Huazhong Univ Sci Technolog Med Sci 2008;28:33-6.
16. Olson FJ, Strömberg S, Hjelmgren O, et al. Increased vascularization of shoulder regions of carotid atherosclerotic plaques from patients with diabetes. J Vas Surg 2011;54:1324-1331.e5.
17. Menezes LJ, Kotze CW, Agu O, et al. Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation. J Nucl Med 2011;52:1698-703.
18. Faggioli GL, Pini R, Mauro R, et al. Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomography. Eur J Vasc Endovasc Surg 2011;41:238-48.
19. Alsheikh-Ali AA, Kitsios GD, Balk EM, et al. The vulnerable atherosclerotic plaque: scope of the literature. Ann Intern Med 2010;153:387-95.
20. Slevin M, Turu MM, Rovira N, et al. Identification of a 'snapshot' of co-expressed angiogenic markers in laser-dissected vessels from unstable carotid plaques with targeted arrays. J Vasc Res 2010;47:323-35.
21. Figueroa AL, Subramanian SS, Cury RC, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012;5:69-77.
22. Businaro R, Tagliani A, Buttari B, et al. Cellular and molecular players in the atherosclerotic plaque progression. Ann N Y Acad Sci 2012;1262:134-41.
23. Cho KY, Miyoshi H, Kuroda S, et al. The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J stroke Cerebrovasc Dis 2013;22:910-8.
24. Medbury HJ, Tarran SL, Guiffre AK, et al. Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 2008;27:114-23.
25. Medbury HJ, James V, Ngo J, et al. Differing association of macrophage subsets with atherosclerotic plaque stability. Int Angiol 2013;32:74-84.